BIOMAT Database Logo BIOMAT Database Logo

[Oxidative deamination data on biogenic monoamines in the mitochondrial fraction of rat brain and liver]. 1981

Zh G Sarukhanian, and E A Babaian, and G V Darbinian

UI MeSH Term Description Entries
D008297 Male Males
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D008930 Mitochondria, Liver Mitochondria in hepatocytes. As in all mitochondria, there are an outer membrane and an inner membrane, together creating two separate mitochondrial compartments: the internal matrix space and a much narrower intermembrane space. In the liver mitochondrion, an estimated 67% of the total mitochondrial proteins is located in the matrix. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p343-4) Liver Mitochondria,Liver Mitochondrion,Mitochondrion, Liver
D008982 Molybdenum A metallic element with the atomic symbol Mo, atomic number 42, and atomic weight 95.95. It is an essential trace element, being a component of the enzymes xanthine oxidase, aldehyde oxidase, and nitrate reductase. Molybdenum-98,Molybdenum 98
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003641 Deamination The removal of an amino group (NH2) from a chemical compound. Deaminations
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Zh G Sarukhanian, and E A Babaian, and G V Darbinian
On the inhibition by harmine of oxidative deamination of biogenic monoamines.
April 1967, Life sciences,
Zh G Sarukhanian, and E A Babaian, and G V Darbinian
Effect of some monoamine oxidase inhibitors on deamination of biogenic monoamines by rat liver mitochondrial monoamine oxidase.
March 1966, Experientia,
Zh G Sarukhanian, and E A Babaian, and G V Darbinian
[The effect of psychotropic substances on the deamination of monoamines in the rat brain].
January 1988, Farmakologiia i toksikologiia,
Zh G Sarukhanian, and E A Babaian, and G V Darbinian
[Deamination of some biogenic monoamines and succinate dehydrogenase activity in mitochondria].
January 1971, Voprosy meditsinskoi khimii,
Zh G Sarukhanian, and E A Babaian, and G V Darbinian
[The effect of hydrocortisone on oxidative deamination of biogenic amines in some parts of the brain and liver of rabbits].
January 1972, Fiziolohichnyi zhurnal,
Zh G Sarukhanian, and E A Babaian, and G V Darbinian
[Oxidative deamination of aminoacetone in the rat liver].
July 1968, Bollettino della Societa italiana di biologia sperimentale,
Zh G Sarukhanian, and E A Babaian, and G V Darbinian
[Deamination of biogenic amines by mitochondrial monoamine oxidase in human fetal liver].
January 1973, Zhurnal evoliutsionnoi biokhimii i fiziologii,
Zh G Sarukhanian, and E A Babaian, and G V Darbinian
Effects of meclofenoxate on the level and turnover of biogenic monoamines in the rat brain.
January 1985, Arzneimittel-Forschung,
Zh G Sarukhanian, and E A Babaian, and G V Darbinian
[Localization of biogenic monoamines in the dura mater of the rat brain].
May 1985, Arkhiv anatomii, gistologii i embriologii,
Zh G Sarukhanian, and E A Babaian, and G V Darbinian
On the selective inhibition by some monoamine oxidase inhibitors of deamination of biogenic monoamines in vivo.
June 1968, Biochemical pharmacology,
Copied contents to your clipboard!